Unlike c-MYC, MYCN is expressed in a specialized EpCAM-positive CSC-like subpopulation of heterogeneous HCC cells, which is selectively eliminated by a candidate chemopreventive agent against HCC recurrence, acyclic retinoid (ACR) (16, 17). Here, EPCAM is linked to hepatocellular carcinoma.